Neoadjuvant sintilimab combined with gemcitabine and cisplatin (GP) for muscle-invasive bladder cancer (MIBC) patients followed by selective bladder sparing surgery

被引：0
|
作者：
Tong, Z. [1 ]
Fu, G. [2 ]
Zhou, F. [2 ]
Liu, X. [3 ]
Xue, X. [4 ]
Zhang, H. [1 ]
Wang, Y. [2 ]
Zhu, X. [1 ]
Gao, Y. [1 ]
Liu, L. [1 ]
Bao, X. [1 ]
Zheng, Y. [1 ]
Fang, W. [1 ]
Zhao, P. [1 ]
Jin, B. [2 ]
机构：
[1] Zhejiang Univ, Dept Med Oncol, Sch Med, Affiliated Hosp 1, Hangzhou, Peoples R China
[2] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Urol, Hangzhou, Peoples R China
[3] Zhejiang Univ, Dept Pathol, Affiliated Hosp 1, Hangzhou, Peoples R China
[4] Zhejiang Univ, Dept Radiol, Affiliated Hosp 1, Sch Med, Hangzhou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2375P
引用
收藏
页码：S1210 / S1210
页数：1
相关论文
共 50 条
  • [31] IMMUNOHISTOCHEMICAL PROFILE OF MUSCLE-INVASIVE BLADDER CANCER (MIBC)
    Ziglioli, Francesco
    Campobasso, Davide
    Barbieri, Antonio
    Campanini, Nicoletta
    Dieli, Rosalia
    Vezzini, Simone
    Ruffini, Livia
    Maestroni, Umberto
    Silini, Enrico Maria
    [J]. ANTICANCER RESEARCH, 2021, 41 (10) : 5293 - 5294
  • [32] Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer
    Einerhand, Sarah M. H.
    Black, Anna J.
    Zargar, Homayoun
    Fairey, Adrian S.
    Dinney, Colin P.
    Mir, Maria C.
    Krabbe, Laura-Maria
    Cookson, Michael S.
    Jacobson, Niels-Erik
    Montgomery, Jeffrey S.
    Vasdev, Nikhil
    Yu, Evan Y.
    Xylinas, Evanguelos
    Kassouf, Wassim
    Dall'Era, Marc A.
    Sridhar, Srikala S.
    McGrath, Jonathan S.
    Aning, Jonathan
    Shariat, Shahrokh F.
    Wright, Jonathan L.
    Thorpe, Andrew C.
    Morgan, Todd M.
    Holzbeierlein, Jeff M.
    Bivalacqua, Trinity J.
    North, Scott
    Barocas, Daniel A.
    Lotan, Yair
    Grivas, Petros
    Garcia, Jorge A.
    Stephenson, Andrew J.
    Shah, Jay B.
    Daneshmand, Siamak
    Zargar-Shoshtari, Kamran
    Spiess, Philippe E.
    van Rhijn, Bas W. G.
    Black, Peter C.
    Mertens, Laura S.
    [J]. WORLD JOURNAL OF UROLOGY, 2022, 40 (11) : 2707 - 2715
  • [33] Neoadjuvant nivolumab (N) plus /- ipilimumab (I) in cisplatin-ineligible patients (pts) with muscle-invasive bladder cancer (MIBC).
    Guercio, Brendan John
    Pietzak, Eugene J.
    Brown, Samantha
    Chen, Jie-Fu
    Peters, Vanessa
    Regazzi, Ashley Marie
    Aggen, David Henry
    Donahue, Timothy F.
    Goh, Alvin C.
    Cha, Eugene K.
    Donat, S. Machele
    Dalbagni, Guido
    Bochner, Bernard H.
    Funt, Samuel Aaron
    Bajorin, Dean F.
    Iyer, Gopa
    Ostrovnaya, Irina
    Al-Ahmadie, Hikmat A.
    Rosenberg, Jonathan E.
    Teo, Min Yuen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [34] Comparative effectiveness of gemcitabine plus cisplatin (GC) versus methotrexate, vinblastine, doxorubicin, plus cisplatin (MVAC) as neoadjuvant therapy for muscle-invasive bladder cancer (MIBC).
    Galsky, Matt D.
    Harshman, Lauren Christine
    Crabb, Simon J.
    Wong, Yu-Ning
    Yu, Evan Y.
    Chowdhury, Simon
    Powles, Thomas
    Pal, Sumanta Kumar
    Moshier, Erin L.
    Ladoire, Sylvain
    Hussain, Syed A.
    Agarwal, Neeraj
    Vaishampayan, Ulka N.
    Recine, Federica
    Berthold, Dominik
    Necchi, Andrea
    Theodore, Christine
    Milowsky, Matthew I.
    Bellmunt, Joaquim
    Rosenberg, Jonathan E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [35] Can neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy improve survival in patients with cisplatin-ineligible muscle-invasive bladder cancer?
    Koie, Takuya
    Suzuki, Yuichiro
    Tobisawa, Yuki
    Yoneyama, Tohru
    Mori, Kazuyuki
    Okamoto, Akiko
    Yamamoto, Hayato
    Imai, Atsushi
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Ohyama, Chikara
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [36] Neoadjuvant atezolizumab (A) with gemcitabine and cisplatin (GC) in patients (pts) with muscle-invasive bladder cancer (MIBC): A multicenter, single-arm, phase 2 trial.
    Funt, Samuel Aaron
    Lattanzi, Michael
    Whiting, Karissa
    Al-Ahmadie, Hikmat A.
    Quinlan, Colleen
    Teo, Min Yuen
    Kamradt, Jeffrey
    Khalil, Maged F.
    Ostrovnaya, Irina
    Mccoy, Asia S.
    Hettich, Grace
    Jihad, Marwah
    Folefac, Edmund
    Huang, William C.
    Bajorin, Dean F.
    Iyer, Gopa
    Bochner, Bernard H.
    Balar, Arjun Vasant
    Mortazavi, Amir
    Rosenberg, Jonathan E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [37] The neoadjuvant management of muscle-invasive bladder cancer (MIBC) in Canada: A national survey of urologists
    Sridhar, Srikala S.
    Chi, Kim N.
    North, Scott A.
    Black, Peter C.
    Wood, Lori
    Hsu, Tina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [38] PHASE 2 TRIAL OF NEOADJUVANT GEMCITABINE AND CARBOPLATIN FOR MUSCLE-INVASIVE BLADDER CANCER FOLLOWED BY RADICAL CYSTECTOMY
    Koie, Takuya
    Okamoto, Teppei
    Imanishi, Kengo
    Sugiyama, Naoki
    Kudoh, Shigemasa
    Mori, Kazuyuki
    Tachiwada, Tokushi
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Kamimura, Noritaka
    Ohyama, Chikara
    Suzuki, Yuichiro
    [J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E657 - E657
  • [39] Neoadjuvant chemotherapy with gemcitabine plus carboplatin followed by immediate radical cystectomy for muscle-invasive bladder cancer
    Ohyama, Chikara
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Koie, Takuya
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 (01) : 3 - 4
  • [40] Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder
    Kim, Hongsik
    Jeong, Byong Chang
    Hong, Joohyun
    Kwon, Ghee Young
    Kim, Chan Kyo
    Park, Won
    Pyo, Hongryull
    Song, Wan
    Sung, Hyun Hwan
    Hong, Jung Yong
    Park, Se Hoon
    [J]. CANCER RESEARCH AND TREATMENT, 2023, 55 (02): : 636 - 642
12345